SS
Shefali Sarkar
About Shefali Sarkar
Data last updated:
Shefali Sarkar is a Director at Lipco Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Lipco Pharmaceuticals Private Limited reported revenue of ₹98.7 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lipco Pharmaceuticals Private Limited U24290MH2020PTC436205 | Director | 31 Aug 2020 | 2020 | ₹98.7 Lakh (FY 2024) | Active |
Board colleagues of Shefali Sarkar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ankita Sarkar | 08856608 | Lipco Pharmaceuticals Private Limited | Director |
| Dikshita Sarkar | 10816589 | Lipco Pharmaceuticals Private Limited | Additional Director |
| Subrata Sarkar | 08856606 | Lipco Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shefali Sarkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shefali Sarkar
Shefali Sarkar currently holds 1 directorship: Lipco Pharmaceuticals Private Limited (Director, since 31 Aug 2020, revenue ₹98.7 Lakh (FY 2024)).
Shefali Sarkar was first appointed on 31 Aug 2020 as Director at Lipco Pharmaceuticals Private Limited.
The current boards of Shefali Sarkar's companies include Ankita Sarkar (Lipco Pharmaceuticals Private Limited), Dikshita Sarkar (Lipco Pharmaceuticals Private Limited), Subrata Sarkar (Lipco Pharmaceuticals Private Limited).